Passive immunization with anti-D can prevent maternal alloimmunization to RhD thereby preventing hemolytic disease of the fetus and newborn. Unexpectedly, anti-D fails in some cases and some monoclonal anti-D preparations paradoxically enhances alloimmunization. The underlying mechanisms modulating humoral alloimmunization by anti-D are unknown. We previously reported that IgG antibody subclasses differentially regulate alloimmunity in response to red blood cell (RBC) transfusions in a mouse model; in particular, IgG2c significantly enhanced RBC alloantibody responses. Initial mechanistic studies revealed that IgG2c:RBC immune complexes were preferentially consumed by the splenic dendritic cell (DC) subsets that play a role in RBC alloimmun...
Antigen-specific IgG antibodies, passively administered to mice or humans together with large partic...
he final differentiation or maturation of dendritic cells (DCs) in response to environmental stimuli...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
It has long been appreciated that immunoglobulins are not just the effector endpoint of humoral immu...
One of the most effective immunological interventions for human disease prevention is the administra...
Circulating immune complexes play an important role in the modulation of antibody responses and in t...
Anti-D is routinely and effectively used to prevent hemolytic disease of the fetus and newborn (HDFN...
The research described in this thesis is aimed towards elucidation of the mechanism of action of ant...
Antibodies passively administered together with their specific antigen can enhance or suppress the s...
BACKGROUND The mechanism of action of anti-D in ameliorating immune thrombocytopenia (ITP) remains u...
<div><p>Antigen-specific IgG antibodies, passively administered to mice or humans together with larg...
The ability of anti-D to prevent hemolytic disease of the fetus and newborn (HDFN) is an example of ...
Antibody responses can be up- or down-regulated by passive administration of specific antibody toget...
A fully human IgG1 kappa antibody (MDE-8) was generated, which recognised Fc-gamma receptor IIa (Fc?...
Antigen-specific IgG antibodies, passively administered together with erythrocytes, prevent antibody...
Antigen-specific IgG antibodies, passively administered to mice or humans together with large partic...
he final differentiation or maturation of dendritic cells (DCs) in response to environmental stimuli...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
It has long been appreciated that immunoglobulins are not just the effector endpoint of humoral immu...
One of the most effective immunological interventions for human disease prevention is the administra...
Circulating immune complexes play an important role in the modulation of antibody responses and in t...
Anti-D is routinely and effectively used to prevent hemolytic disease of the fetus and newborn (HDFN...
The research described in this thesis is aimed towards elucidation of the mechanism of action of ant...
Antibodies passively administered together with their specific antigen can enhance or suppress the s...
BACKGROUND The mechanism of action of anti-D in ameliorating immune thrombocytopenia (ITP) remains u...
<div><p>Antigen-specific IgG antibodies, passively administered to mice or humans together with larg...
The ability of anti-D to prevent hemolytic disease of the fetus and newborn (HDFN) is an example of ...
Antibody responses can be up- or down-regulated by passive administration of specific antibody toget...
A fully human IgG1 kappa antibody (MDE-8) was generated, which recognised Fc-gamma receptor IIa (Fc?...
Antigen-specific IgG antibodies, passively administered together with erythrocytes, prevent antibody...
Antigen-specific IgG antibodies, passively administered to mice or humans together with large partic...
he final differentiation or maturation of dendritic cells (DCs) in response to environmental stimuli...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...